# Stress hyporesponsive period as biological precedent for ARC-046 infant hazard protection

**Claim:** ARC-046 — "The infant stage requires a hazard protection mechanism that permits sensorially salient harm exposure without catastrophic residue saturation."

**Source:** Suchecki D (2018), *Journal of Neuroendocrinology* 30(7):e12610. According to PubMed, [DOI 10.1111/jne.12610](https://doi.org/10.1111/jne.12610), PMID 29774962. Direction: **supports** (confidence 0.74).

## What the paper says

This is a review, written in honour of Seymour "Gig" Levine, of the **stress hyporesponsive period (SHRP)** — a developmental window (roughly the first two postnatal weeks in the rat) during which the neonate's hypothalamic-pituitary-adrenal (HPA) axis mounts a markedly *attenuated* corticosterone response to stressors that would strongly activate the adult axis. Levine's serendipitous finding was that this attenuation is not simply passive immaturity: maternal behaviours actively regulate it. Anogenital licking/grooming inhibits stress-induced ACTH release, feeding suppresses the corticosterone response, and the combination prevents the HPA disinhibition that follows prolonged (24 h) maternal deprivation. The review frames the SHRP as an adaptive protection of the developing brain from glucocorticoid exposure, with the quality of early social regulation setting the trajectory toward later resilience or susceptibility to stress-related psychiatric disorders.

## How it maps to REE

ARC-046 asserts that infant harm exposure must be *educative* — the nociceptive/harm pathways (`z_harm_s`, `z_harm_a`) fire normally so harm geography gets populated — but *not destructive*, achieved by holding residue accumulation to ~10% of the adult rate (`residue_scale_factor ~0.1`) and/or scaling down `hazard_magnitude`. The SHRP is the cleanest biological precedent I have found for exactly this decoupling. In the neonate, the stress *signal* is registered and the animal learns, but the damaging downstream load — circulating glucocorticoid — is held to a fraction of the adult level. Substitute "residue field" for "corticosterone" and the SHRP is structurally the same protective bargain ARC-046 strikes: keep the teaching signal, suppress the saturating damage.

The maternal-regulation half of the paper maps onto the claim's invocation of INV-043's caregiver function, "imperfect protection: allow harm-learning without destruction." In Levine's paradigm the dam *is* the attenuating mechanism, and its protection is graded and defeasible (prolonged deprivation disinhibits the axis) rather than absolute — which matches ARC-046's note that in the single-agent CausalGridWorld the protection is a curriculum parameter that is *progressively removed* as the agent matures, with full caregiver modelling deferred to the multi-agent substrate (ARC-047).

## Limitations and caveats

This is an analogy between a neuroendocrine load variable and an abstract architectural one. The SHRP literature never measures anything called "residue"; REE has no HPA axis. The equivalence "attenuated corticosterone ≈ attenuated residue, with sensation intact" is the design rationale the analogy *supports*, not a measured identity. The evidence is also predominantly rodent — the human SHRP is more contested and less sharply bounded — so the species transfer compounds the level-of-description transfer. I have therefore weighted `transfer_risk` up (0.40) and held overall confidence at 0.74 despite the high quality and replication status of the underlying phenomenon. What the paper does *not* tell us is whether the protective attenuation can be tuned independently of the teaching signal in an artificial substrate; that is precisely what ARC-046's experiments (e.g. the V3-EXQ-591 cluster) have to establish empirically.

## Why included

The SHRP is the canonical real-world existence proof that a developing nervous system can keep its harm-detection machinery online while clamping the accumulating damage that machinery would otherwise inflict — and that this clamp is an actively regulated, caregiver-coupled, progressively-released set-point rather than mere weakness. That is ARC-046's architectural commitment, stated in neuroendocrine rather than computational vocabulary.
